Cargando…
Specific thresholds of quantitative pupillometry parameters predict unfavorable outcome in comatose survivors early after cardiac arrest
AIM: Quantitative pupillometry is the guideline-recommended method for assessing pupillary light reflex for multimodal prognostication in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA). However, threshold values predicting an unfavorable outcome have been inconsistent acro...
Autores principales: | Nyholm, Benjamin, Obling, Laust Emil Roelsgaard, Hassager, Christian, Grand, Johannes, Møller, Jacob Eifer, Othman, Marwan H., Kondziella, Daniel, Kjaergaard, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220278/ https://www.ncbi.nlm.nih.gov/pubmed/37252025 http://dx.doi.org/10.1016/j.resplu.2023.100399 |
Ejemplares similares
-
Quantitative pupillometry for neuroprognostication in comatose post-cardiac arrest patients: A protocol for a predefined sub-study of the Blood pressure and Oxygenations Targets after Out-of-Hospital Cardiac Arrest (BOX)-trial
por: Nyholm, Benjamin, et al.
Publicado: (2023) -
Superior reproducibility and repeatability in automated quantitative pupillometry compared to standard manual assessment, and quantitative pupillary response parameters present high reliability in critically ill cardiac patients
por: Nyholm, Benjamin, et al.
Publicado: (2022) -
Serial assessments of cardiac output and mixed venous oxygen saturation in comatose patients after out-of-hospital cardiac arrest
por: Grand, Johannes, et al.
Publicado: (2023) -
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
por: Obling, Laust Emil Roelsgaard, et al.
Publicado: (2022) -
Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial
por: Meyer, Martin Abild Stengaard, et al.
Publicado: (2021)